Kestra Medical Technologies (KMTS) Return on Equity (2024 - 2026)
Kestra Medical Technologies (KMTS) has disclosed Return on Equity for 3 consecutive years, with 0.6% as the latest value for Q1 2026.
- Quarterly Return on Equity fell 64.0% to 0.6% in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.6% through Jan 2026, down 64.0% year-over-year, with the annual reading at 53.16% for FY2025, N/A changed from the prior year.
- Return on Equity for Q1 2026 was 0.6% at Kestra Medical Technologies, up from 0.71% in the prior quarter.
- The five-year high for Return on Equity was 4.02% in Q2 2025, with the low at 0.71% in Q4 2025.
- Average Return on Equity over 3 years is 0.37%, with a median of 0.27% recorded in 2025.
- The sharpest move saw Return on Equity plummeted -75bps in 2025, then crashed -64bps in 2026.
- Over 3 years, Return on Equity stood at 0.04% in 2024, then plummeted by -1792bps to 0.71% in 2025, then rose by 15bps to 0.6% in 2026.
- According to Business Quant data, Return on Equity over the past three periods came in at 0.6%, 0.71%, and 0.57% for Q1 2026, Q4 2025, and Q3 2025 respectively.